1-methoxy-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperazine
Structure Info
- Chemspace ID
- CSSB02533284463 (In-Stock Building Blocks)
- IUPAC Name
- 1-methoxy-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperazine
- Mol formula
- C18H27BN2O4
- Mol weight
- 346 Da
- Catalog Number(s)
- BBLS02533284463, BBV-332013309, EN300-55348521, bbls02533284463
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.67
- Heavy atoms count
- 25
- Rotatable bond count
- 3
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.611
- Polar surface area (Å)
- 51
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 0
![Chemical structure of 1-methoxy-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperazine (C18H27BN2O4) - CSSB02533284463](/st/structure/200/40ace809d163c383e13c74dd41cdc3e9/CON1CCN%2528CC1%2529C%2528%253DO%2529C1%253DCC%253DC%2528C%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png "C18H27BN2O4")
- Zoom the structure
- CSSB02533284463
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 360.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 376.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 393.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 410.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 427.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 838.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,240.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 1,839.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 4-fluoro-4-methyl-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperidine - CSSB02533509425](/st/structure/200/c03fe23180fc3113960f37b645536b05/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CCC%2528C%2529%2528F%2529CC1.png)
![Chemical structure of 1-methoxy-4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperazine - CSSB02229498536](/st/structure/200/aab56d6ec0cd1c794a3e73fbdf1d239a/CON1CCN%2528CC1%2529C%2528%253DO%2529C1%253DCC%253DCC%2528%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 1-ethyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperazine - CSSB00025702296](/st/structure/200/20e085d597b2d39583fd1e9bfab24b11/CCN1CCN%2528CC1%2529C%2528%253DO%2529C1%253DCC%253DC%2528C%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine - CSSB02495332704](/st/structure/200/b0ab47fa2fa3753c993e241ee96f7e9d/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CCC1.png)
![Chemical structure of 1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]pyrrolidine - CSSB00000062364](/st/structure/200/669baba317bf884a2a2884d3eba6c9bd/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CCCC1.png)
![Chemical structure of 1-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperazine - CSSB00000038498](/st/structure/200/b25b816f4ba7a92964ebc21d69f3afb7/CN1CCN%2528CC1%2529C%2528%253DO%2529C1%253DCC%253DC%2528C%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]morpholine - CSSB00015192221](/st/structure/200/7381d3895ae8d3394fb733077f1afda8/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CCOCC1.png)
